Shanghai Junshi Biosciences Co., Ltd, will collaborate with Dr. Reddy’s Laboratories to develop and commercialize toripalimab, the anti-PD-1 monoclonal antibody in Latin America, India, South Africa, and at the election of Dr. Reddy’s, also in Australia, New Zealand and other countries. Under the license and commercialization agreement, Junshi Biosciences will grant a license to Dr. Reddy’s to develop and exclusively commercialize toripalimab in Brazil, Mexico, Colombia, Argentina, Peru, Chil...